FDA Modernization Act 2.0: transitioning beyond animal models with human cells, organoids, and AI/ML-based approaches
J Clin Invest
.
2023 Nov 1;133(21):e175824.
doi: 10.1172/JCI175824.
Authors
Peter-James H Zushin
1
2
,
Souhrid Mukherjee
3
,
Joseph C Wu
1
2
3
Affiliations
1
Stanford Cardiovascular Institute and.
2
Department of Medicine (Division of Cardiology), Stanford University, Stanford, California, USA.
3
Greenstone Biosciences, Palo Alto, California, USA.
PMID:
37909337
PMCID:
PMC10617761
DOI:
10.1172/JCI175824
No abstract available
Publication types
Research Support, N.I.H., Extramural
MeSH terms
Animals
Drug Approval*
Humans
Models, Animal
Organoids*
United States
United States Food and Drug Administration
Grants and funding
T32 EB009035/EB/NIBIB NIH HHS/United States
R01 HL130020/HL/NHLBI NIH HHS/United States
R01 HL146690/HL/NHLBI NIH HHS/United States
R01 HL141371/HL/NHLBI NIH HHS/United States
R01 HL145676/HL/NHLBI NIH HHS/United States
R01 HL141851/HL/NHLBI NIH HHS/United States